Depression is a severe, common mental health disorder with complex contributing
factors. It is a severe problem in modern medicine, because standard therapies (such
as pharmacological and psychotherapy) often are not enough to achieve complete
symptom relief. Encouragingly, the role of gut microbiota in the development and
progression of mental disorders may open new therapeutic pathways. In this study,
we aimed to summarize the role of the gut microbiota in the pathogenesis of
depression. The potential therapeutic benefits of modulating this system are also
important. This study demonstrates how a personalized approach to each patient
can improve treatment outcomes.
Keywords: gut microbiota; gut–brain axis; depression; psychobiotics; inflammation
